CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.
Saved in:
| Title: | CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma. |
|---|---|
| Authors: | Wang, Xueying1 (AUTHOR), Tang, Xuemei2 (AUTHOR), Gu, Jiahui1 (AUTHOR), Sun, Ziwei1 (AUTHOR), Yang, Shengrui1 (AUTHOR), Mu, Yuan1,3 (AUTHOR), Guan, Ming2,4 (AUTHOR), Chen, Kun4 (AUTHOR), Liu, Wei5 (AUTHOR), Ruan, Haoyu1,3 (AUTHOR) rhy1170871576@163.com, Xu, Jian1,3 (AUTHOR) xujian@njmu.edu.cn |
| Source: | Cancer Medicine. Feb2023, Vol. 12 Issue 4, p4521-4529. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
